IOL Chemicals and Pharmaceuticals Ltd

IOL Chemicals and Pharmaceuticals Legal & Regulatory

IOL Chemicals paid a ₹0.0002 Crore fine to BSE for a one-day delay in filing shareholding patterns. The company cited an inadvertent interpretational oversight.

IOL Chemicals and Pharmaceuticals Q4 FY26 Results: Net Profit ₹53.2 Cr, Up 69.4% YoY

IOL Chemicals and Pharmaceuticals Ltd reported revenue from operations of ₹619.5 Cr (+17.4% YoY) and net profit of ₹53.2 Cr (+69.4% YoY) for Q4 FY26.

Key figure

Net profit ₹53.2 Cr · +69.4% YoY

IOL Chemicals and Pharmaceuticals Financial Results

IOL Chemicals reported annual consolidated net profit of ₹137.64 Crore. The company also announced a ₹22.75 Crore capacity expansion for Triacetin and Pantoprazole products.

Value

₹22.75 Cr

IOL Chemicals and Pharmaceuticals Board Meeting Date

IOL Chemicals & Pharmaceuticals Ltd will hold a board meeting on May 20, 2026. Directors will consider audited standalone and consolidated financial results.